BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2685693)

  • 21. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
    Krause T; Eisenmann N; Reinhardt M; Bathmann J; Altehoefer C; Finke J; Moser E
    Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative magnetic resonance studies of lumbar vertebral marrow in patients with refractory or relapsed Hodgkin's disease.
    Smith SR; Williams CE; Edwards RH; Davies JM
    Ann Oncol; 1991 Feb; 2 Suppl 2():39-42. PubMed ID: 2049319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow involvement by hodgkin and non-hodgkin lymphomas.
    Zhang QY; Foucar K
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):873-902. PubMed ID: 19577173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bone marrow involvement in Hodgkin's disease: MR tomography and chemical-shift imaging].
    Kauczor HU; Bentz M; Bischoff H; Gückel F; Döhner H; Brix G; van Kaick G
    Rofo; 1993 Dec; 159(6):555-61. PubMed ID: 8298116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases.
    Brunning RD; Bloomfield CD; McKenna RW; Peterson LA
    Ann Intern Med; 1975 Mar; 82(3):365-6. PubMed ID: 1172924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The superiority of histologic sections of aspirated bone marrow in malignant lymphomas. A review of 1,124 examinations.
    Liao KT
    Cancer; 1971 Mar; 27(3):618-28. PubMed ID: 5107906
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bone marrow scintigraphy and magnetic resonance tomography in plasmacytoma].
    Ruhlmann J; Bockisch A; Dewes W; Loos U; Hotze A; Biersack HJ
    Onkologie; 1989 Aug; 12 Suppl 1():38-41. PubMed ID: 2685694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations.
    Negendank WG; al-Katib AM; Karanes C; Smith MR
    Radiology; 1990 Oct; 177(1):209-16. PubMed ID: 2399318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fat replacement of Hodgkin disease of bone marrow after chemotherapy: report of three cases.
    Lien HH; Holte H
    Skeletal Radiol; 1996 Oct; 25(7):671-4. PubMed ID: 8915054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Nucl Med Commun; 2016 Jan; 37(1):23-9. PubMed ID: 26440567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR imaging of primary lymphoma of bone: variability of T2-weighted signal intensity.
    White LM; Schweitzer ME; Khalili K; Howarth DJ; Wunder JS; Bell RS
    AJR Am J Roentgenol; 1998 May; 170(5):1243-7. PubMed ID: 9574594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The importance of bone marrow examination for hemoblastoses].
    Döhner H; Ehrhardt R
    Radiologe; 1992 Oct; 32(10):481-4. PubMed ID: 1438716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy and relative value of bone marrow aspiration in the detection of lymphoid infiltration in non-Hodgkin lymphoma.
    Musolino A; Guazzi A; Nizzoli R; Panebianco M; Mancini C; Ardizzoni A
    Tumori; 2010; 96(1):24-7. PubMed ID: 20437853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [MR tomography in lymphatic and leukemic bone marrow infiltrations. A comparison with scintigraphy and conventional x-ray diagnosis].
    Dewes W; Ruhlmann J; Loos U; Vogel J; Krahe T; Hotze A; Harder T
    Rofo; 1987 Dec; 147(6):654-61. PubMed ID: 2827260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
    Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
    Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of histology of bone marrow trephine in malignant lymphomas.
    Durosinmi MA; Mabayoje VO; Akinola NO
    Niger J Med; 2003; 12(4):198-201. PubMed ID: 14768193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
    Ribrag V; Vanel D; Leboulleux S; Lumbroso J; Couanet D; Bonniaud G; Aupérin A; Masson F; Bosq J; Edeline V; Fermé C; Pigneur F; Schlumberger M
    Eur J Radiol; 2008 May; 66(2):325-31. PubMed ID: 17651934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look.
    Ebie N; Loew JM; Gregory SA
    Hematol Pathol; 1989; 3(1):29-33. PubMed ID: 2745358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Malignant bone marrow infiltration in nuclear magnetic resonance tomography].
    Gamillscheg A; Urban C; Ranner G; Kaulfersch W; Lackner H; Hauer C; Slavc I; Schmid G
    Padiatr Padol; 1989; 24(2):103-11. PubMed ID: 2761997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.